Merrion Pharmaceuticals Plc (3MP):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82696FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Merrion Pharmaceuticals Plc (Merrion) is a product development company. It offers prescription pharmaceutical products to meet unmet needs in healthcare. The company focuses on the development of drugs in oral forms such as tablets and capsules that have limited absorption, and are generally given by injection. It has developed GIPET, a patented drug delivery technology that increases bioavailability, by enhancing absorption levels in the gastrointestinal tract. Merrion’s product portfolio includes Orazol, Almero, Acyline and MER-102. Its products find application in the treatment of diseases such as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has agreements with several pharmaceutical companies; and through its license agreements with Novo Nordisk A/S develops and commercializes oral forms of Novo Nordisk’s Insulin and GLP-1, by utilizing the GIPET technology. Merrion is headquartered in Dublin, Ireland.

Merrion Pharmaceuticals Plc Key Recent Developments

Dec 23, 2013: Merrion Pharmaceuticals Announces Appointment of Director
Dec 23, 2013: Merrion Pharmaceuticals Announces Appointment of CEO and Chairman
Sep 30, 2013: Interim Results for the Six Months Ended 30 June 2013
Aug 20, 2013: Merrion Pharmaceuticals Announces Appointment of Non-Executive Director

This comprehensive SWOT profile of Merrion Pharmaceuticals Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Merrion Pharmaceuticals Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Merrion Pharmaceuticals Plc – Key Information
Merrion Pharmaceuticals Plc – Overview
Merrion Pharmaceuticals Plc – Key Employees
Merrion Pharmaceuticals Plc – Key Employee Biographies
Merrion Pharmaceuticals Plc – Key Operational Heads
Merrion Pharmaceuticals Plc – Major Products and Services
Merrion Pharmaceuticals Plc – History
Merrion Pharmaceuticals Plc – Company Statement
Merrion Pharmaceuticals Plc – Locations And Subsidiaries
Merrion Pharmaceuticals Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Merrion Pharmaceuticals Plc – Business Description
Merrion Pharmaceuticals Plc – Corporate Strategy
Merrion Pharmaceuticals Plc – SWOT Analysis
SWOT Analysis – Overview
Merrion Pharmaceuticals Plc – Strengths
Merrion Pharmaceuticals Plc – Weaknesses
Merrion Pharmaceuticals Plc – Opportunities
Merrion Pharmaceuticals Plc – Threats
Merrion Pharmaceuticals Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Merrion Pharmaceuticals Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Merrion Pharmaceuticals Plc, Key Information
Merrion Pharmaceuticals Plc, Key Ratios
Merrion Pharmaceuticals Plc, Share Data
Merrion Pharmaceuticals Plc, Major Products and Services
Merrion Pharmaceuticals Plc, History
Merrion Pharmaceuticals Plc, Key Employees
Merrion Pharmaceuticals Plc, Key Employee Biographies
Merrion Pharmaceuticals Plc, Key Operational Heads
Merrion Pharmaceuticals Plc, Other Locations
Merrion Pharmaceuticals Plc, Subsidiaries
Merrion Pharmaceuticals Plc, Key Manufacturing facilities
Merrion Pharmaceuticals Plc, Key Competitors
Merrion Pharmaceuticals Plc, SWOT Analysis
Merrion Pharmaceuticals Plc, Ratios based on current share price
Merrion Pharmaceuticals Plc, Annual Ratios
Merrion Pharmaceuticals Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Merrion Pharmaceuticals Plc, Performance Chart
Merrion Pharmaceuticals Plc, Ratio Charts

★海外企業調査レポート[Merrion Pharmaceuticals Plc (3MP):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Rheinmetall Munitions, Inc.:企業の戦略・SWOT・財務分析
    SummaryAmerican Rheinmetall Munitions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Ormat Nevada, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ormat Nevada, Inc. Mergers and …
  • Cogstate Limited (CGS):(医療機器分野)企業M&A及び提携動向
    Summary CogState Limited (CogState) is a cognitive science company. The company provides products and services in healthcare, clinical trials, sports and academic research. It concentrates on the development and commercialization of rapid, computerized tests of cognition (brain function). CogState’s …
  • Terremark Worldwide, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Terremark Worldwide, Inc. Merge …
  • ITM Power Plc (ITM):企業の財務・戦略的SWOT分析
    ITM Power Plc (ITM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Crown Energy AB(石油・ガス分野):企業M&A動向
    Summary Crown Energy AB (Crown Energy), is an oil and gas company. It focuses on the acquisition, exploration and development of oil and gas projects located in the under-explored areas. The company has projects located in Equatorial Guinea, South Africa and Madagascar regions. In Equatorial Guinea …
  • BAE Systems Australia:企業の戦略・SWOT・財務分析
    SummaryBAE Systems Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Marksans Pharma Limited (MARKSANS):企業の財務及び戦略的SWOT分析
    Summary Marksans Pharma Ltd. is a pharmaceutical company that develops, manufactures, and sells branded formulations and generic products. It also provides contract research and manufacturing services (CRAMS) to various pharmaceutical companies. The company’s focus therapy segments include antibioti …
  • National Western Life Insurance Company:企業の戦略・SWOT・財務分析
    SummaryNational Western Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Chevron Corporation (CVX)(エネルギー分野):企業M&A動向
    Summary Chevron Corporation (Chevron) is an integrated oil and gas company. The company operates across the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. It also carries out petrochemical …
  • Orion Marine Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Orion Marine Group, Inc. Merger …
  • AFGlobal Corporation:企業のM&A・提携動向(石油・ガス分野)
    Summary AFGlobal Corporation (AFGlobal), formerly Ameriforge Group Inc. is a technology company that offers precision engineering services. The company provides fully integrated turnkey and supply chain solutions. It offers a wide range of materials such as drive systems, wheels and other critical c …
  • Jamaica Public Service Company Limited:企業のM&A・提携動向(発電分野)
    Summary Jamaica Public Service Company Limited (JPS) is an integrated electric utility which generates, procures, transmits, distributes and supplies power. It produces electricity from heavy fuel oil, automotive diesel oil, and hydro sources; and procures energy from independent power producers. Th …
  • Cobra Gestion de Infraestructuras, S.L.U.:企業のM&A・提携動向(エネルギー分野)
    Summary Cobra Gestion de Infraestructuras, S.L.U. (Grupo Cobra) is an engineering and infrastructure company which develops, builds and operates industrial infrastructures that require a high level of service. The company undertakes projects in the areas of renewable energy sources and the environme …
  • Cipla Limited:企業のM&A・提携・投資分析
    Cipla Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cipla Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Takeuchi Mfg. Co., Ltd. (6432):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Takeuchi Mfg. Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly f …
  • Sefton Resources, Inc. (SER):企業概要、財務及び戦略的SWOT分析
    Summary Sefton Resources, Inc. (Sefton) is an oil and gas production company. The company explores, develops and produces crude oil and natural gas resources. Its core area of activity is the East Ventura Basin in California. Sefton owns 100% of two oil fields, such as Tapia Canyon (heavy oil) and E …
  • Theranostics Health Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • Virobay Inc.(製薬・医療分野):企業M&A動向
    Summary Virobay Inc. (Virobay) is a pharmaceutical company. The company develops protease inhibitors to treat hepatitis C, neuropathic pain, autoimmune diseases, liver diseases and cancer. Its products include VBY-376, VBY-106 for the treatment of hepatitis C, VBY-129, VBY-891, VBY-036 for autoimmun …
  • Zagrebacka banka d.d.:企業の戦略・SWOT・財務分析
    SummaryZagrebacka banka d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆